Metastatic lymph node density (ND) has been reproducibly proven to be a prognostic factor
in gastric cancer. The molecular mechanisms that underlie this aggressiveness are …

We previously demonstrated that the lymph node ratio (LNR) is a prognostic factor
associated with EGFR expression, among first priority genes amplified or overexpressed in …

Background: Colorectal cancer (CRC) is a common human malignancy. Epidermal growth
factor receptor (EGFR) is expressed in wide variety of human malignancies and is of some …

TNM staging is no doubt the most critical prognostic factors, representing tumor (T)/lymph
node metastasis (N)/distant metastasis (M) in gastric cancer. Lymph node ratio-based N …

Background: As key molecules that drive progression and chemoresistance in
gastrointestinal cancers, epidermal growth factor receptor (EGFR) and human epidermal …

Epidermal growth factor receptor (EGFR) expression and gene copy number have been
observed to be associated with a positive clinical response to EGFR inhibitors. The present …

The expression of epidermal growth factor receptor (EGFR) has been linked to clinical
outcome in several solid tumors. However, the clinical significance of EGFR (c‑erbB1) in …

The epidermal growth factor receptor (EGFR) is an oncogenic trans-membranous receptor,
which is overexpressed in multiple human cancers. However, the role of EGFR in gastric …

Background In gastric cancer, the recurrence rate is high even after curative surgery. A
relevant issue is the identification of independent prognostic factors to select high‐risk …

Objectives: High epidermal growth factor receptor (EGFR) expression in the primary tumor
predicts poor survival in colorectal cancer. However, EGFR expression may be discordant in …